Sok Kang

Sok Kang has over 19 years of experience in regulatory affairs, working in various roles and companies. Most recently, they served as the Director of Regulatory Affairs Strategy at Taiho Oncology, Inc. since January 2021. Prior to that, they worked as the Director of Global Regulatory Lead at Mallinckrodt Pharmaceuticals from 2018 to 2021, where they developed and implemented regulatory strategies for autoimmune and rare diseases.

Before their role at Mallinckrodt Pharmaceuticals, Sok worked as an Associate Director of Regulatory Affairs at Trevena, Inc. from 2015 to 2017. In this position, they served as the regulatory lead and liaison with the FDA for all development products and was responsible for communication regarding regulatory submissions and responses.

From 2013 to 2015, Sok worked as an Associate Director of Regulatory Affairs at Aqua Pharmaceuticals, LLC. Here, they led the submission and coordination of regulatory applications with the Division of Anti-Infective Products and managed all submissions to the FDA.

Sok also gained experience as a Senior Manager of Regulatory Affairs at Endo Pharmaceuticals Inc. from 2012 to 2013. In this role, they were the regulatory lead for a multinational phase 3 global program in oncology and prepared the team for meetings with regulatory authorities.

Prior to that, Sok served as a Senior Manager of Regulatory Affairs at Ono Pharma USA from 2006 to 2012. Here, they were the global regulatory lead and regional regulatory manager for North America, overseeing a multinational phase 2 global clinical trial.

Earlier in their career, Sok worked at Teva Neuroscience from 2002 to 2006. Sok started as a Regulatory Affairs Associate and was later promoted to Senior Regulatory Analyst. In these roles, they led regulatory projects for various drug development products and served as an FDA liaison.

Overall, Sok Kang has extensive experience in regulatory affairs, serving in leadership roles and overseeing regulatory strategies, submissions, and interactions with regulatory authorities.

Sok Kang completed their education as follows:

From 1996 to 2002, Sok Kang attended the Temple University School of Pharmacy, where they earned a Doctor of Pharmacy (Pharm.D.) degree. The field of study for this degree is not specified.

Prior to their time at Temple University, from 1992 to 1996, Sok Kang attended Penn State University. Sok completed their Bachelor's degree in Electrical and Electronics Engineering during this period.

Before attending college, Sok Kang completed their high school education at Bensalem High School from 1988 to 1992. The specific degree or field of study for this period is not provided.